Browsing "Pathology" by Keyword : Cell Line, Tumor
Showing results 21 to 29 of 29
Pub Year | | Title | Author(s) |
2010 | | Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. | 김영배, 여말희, 이광재, 정재연, 조성원 |
2022 | | miR-4742–5p promotes invasiveness of gastric cancer via targeting Rab43: An in vitro study | 김석휘, 김유선, 이다근 |
2013 | | NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. | 김영배, 손영배, 임현이, 정선용, 진현석, 한재호 |
2019 | | PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin | 변혜은, 이다근 |
2021 | | Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer | 김석휘, 이다근, 한재호 |
2012 | | Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis | 김영배, 조혜성, 채선영 |
2007 | | Syndecan-1, a key regulator of cell viability in endometrial cancer. | 유희석, 한재호 |
2019 | | Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer | 손상용, 이다근, 최경숙, 한상욱, 함인혜, 허훈 |
2015 | | Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition. | 김영배, 왕희정 |
1